Moreno-Urbina SI, Ramos-Estrada JG, Valdez-Payán NH

Language: Spanish
References: 7
Page: 50-53
PDF size: 274.72 Kb.

ABSTRACT

Hodgkin’s lymphoma represents approximately 20% of the lymphoproliferative syndromes and is more frequent in young patients. However, the association of this neoplasm and eosinophilia is a very rare condition and there is little evidence in recent literature. This paper reports the case of a female patient of the 3rd decade of life who presented to our service with severe hypereosinophilia and multisystemic symptoms and without evidence of malignancy at the beginning, later she developed a lymph node conglomerate that lead to definitive diagnosis. This is an illustrative case of a rare association.

REFERENCES

1. Chusid DC, West BC, Wolf SM. The hypereosinophilic syndrome. Analysis of fourteen cases with review of the literature. Medicine 1975;54(1):1-27.

2. GLOBOCAN 2012 (IARC) Section of Cancer Surveillance. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012, Mexico. (http://globocan. iarc.fr/Pages/fact_sheets_population.aspx).

3. Vaughan Hudson B, Linch DC, Macintyre EA, et al. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin’s disease (BNLI Report No 31). British National Lymphoma Investigation. J Clin Pathol 1987;40:247-50.

4. Jin J, Butterfield J, Weiler C, Weiler CR. Hematologic malignancies identified in patients with hypereosinophilia and hypereosinophilic syndromes. J Allergy Clin Immunol Pract 2015;(6):920-5.

5. Gobbi PG, Cavalli C, Gendarini A et al. Reevaluation of prognostic significance of symptoms in Hodgkin’s disease. Cancer 1985;56(12):2874-80.

6. Perifanis V, Sfikas G, Tziomalos K, et al. Skin involvement in Hodgkin’s disease. Cancer Invest 2006;24(4):401-3.

7. Di Biagio E, Sánchez-Borges M, Desenne JJ, et al. Eosinophilia in Hodgkin’s disease: a role for interleukin 5. Int Arch Allergy Immunol 1996;110(3):244-51.